Jeannette Ho is a Senior Director at Evonik and leads our surface modification business. She joined Evonik in 2019 as part of the Company’s acquisition of the Endexo® surface modification technology platform from Interface Biologics, a Canadian-based company. She co-founded Interface Biologics in 2001, where she held several senior positions including Director of R&D, Director of Operations and Vice President of Product Development. As part of the senior leadership team of Interface Biologics, Jeannette played a key role in the development and commercialization of the Endexo® technology. She has extensive expertise across material science, polymer science, biomaterials, manufacturing processes, and medical device development, and holds a B.A.Sc. in Chemical Engineering from the University of Waterloo and a M.A.Sc. from the University of Toronto. Jeannette is the inventor on 12 patents, the author of 4 peer-reviewed publications, and is located in Toronto, Canada.
